Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We would be delighted if you could join us for the day on 26 March 2018 to celebrate the inauguration of the Oxford Centre for Haematology, a new initiative that will bring together clinical and research staff across the university and hospitals in Oxford, in collaboration with commercial partners.

Rdm career day 1 John Cairns

The Centre will deliver programmes ranging from world-leading mechanistic science to clinical trials, with the aim of improving the understanding and treatment of blood diseases and disorders, and to deliver the best available care to patients.

The day will start with an introduction to the Centre followed by a series of talks from local, national and international speakers highlighting how haematology is being transformed by combining step changes in science and medicine. We would like all our colleagues on both research and clinical sides to join us including young scientists, trainees, nursing, pharmacy and administrative colleagues.

Please register for the event here. There is a £50 registration which can be paid securely via the University's online shop.

More about Keble College can be found here


Meeting Programme

8:30-9:00    Registration and coffee
9:00-9:10    Welcome - Prof. Paresh Vyas (Director of the Oxford Centre of Haematology)
9:10-9.15    Opening Address - Prof. Hugh Watkins (Head of the Radcliffe Department of Medicine)
9.15-9.20    Opening address - Dr Bruno Holthof (CEO of Oxford University Hospitals)


Immunology, Inflammation and Stem Cell transplantation

9.20 - 9.45    Prof Irv Weissman - Normal and Neoplastic Stem Cells
9.45 - 10.10    Prof Fiona Powrie - Immune pathways in the intestine in health  and disease
10.10-10.35    Dr Andy Peniket & Prof Charles Craddock - Accelerating improvements in stem cell transplant outcome- a Birmingham/Oxford perspective

Lymphoid Disorders

10.35 - 11.00    Prof Jude Fitzgibbon - Follicular Lymphoma, it's not just the t(14;18) anymore
11.00 - 11.25    Dr Karthik Ramasamy & Dr Sarah Gooding - Oxford Myeloma programme: a foundation for science and clinical trials.

Red Cells, Iron and Coagulation

11.45 - 12.05    Prof Doug Higgs - Gene editing of the human alpha globin locus as a treatment for thalassaemia.
12.05 - 12.25    Prof Stuart Orkin - Reactivation of fetal haemogobin
12.25 - 12.50    Prof Martina Muckenthaler - Macrophages - between iron metabolism and inflammation

12.50 - 1.15       Prof Mike Laffan - Von Willebrand factor and the circulation


Myeloproliferative Disorders and Paediatric Haematology

2.00 -2.25    Prof Tony Green - Myeloproliferative neoplasms – from pathogensis to personalized predictions
2.25 - 2.50    Dr Beth Psaila - Megakaryocyte and erythroid progenitors in normal human haemopoiesis and in myelofibrosis
2.50 - 3.15    Prof Adam Mead - Single cell analysis of CML stem cells

Normal haemopoiesis and Leukaemia

3.45 -4.10     Prof Claus Nerlov - Advances in Normal haemopoietic stem and progenitor biology
4.10 - 4.35    Prof Cristina Lo Celso - Studying the normal and malignant haemopoietic niche
4.35 - 5.00    Prof Paresh Vyas - Haemopoietic hierarchy in normal human haemopoiesis and in AML
5.00 - 5.25    Dr Lynn Quek - IDH inhibitor therapy in AML - studying clonal structures in stem/progenitor cells: impact of therapy
5.25 - 5.50    Prof Gil McVean - Genomic Analysis of Biomedical Big Data
5.50 - 6.00    Prof Paresh Vyas - Closing remarks

6.00    Drinks Reception



Register here for the meeting

Find out more

About Us

The Oxford Centre for Haematology is a new initiative spanning the University of Oxford and the Oxford University Hospitals NHS Foundation Trust. It is a virtual centre bringing together researchers and clinicians working in haematology to improve the understanding and treatment of blood diseases and disorders, and to deliver the best available care to patients.

Find out more